PubMed (OMIM) for id: 325450

Year	Number of Results
1988	1
1992	1
1993	2
1994	10
1995	23
1996	9
1997	6
1998	10
1999	7
2000	3
2001	14
2002	7
2003	3
2004	5
2023	0

1

Ink4a/Arf expression is a biomarker of aging.

Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, Sharpless NE. Krishnamurthy J, et al. J Clin Invest. 2004 Nov;114(9):1299-307. doi: 10.1172/JCI22475. J Clin Invest. 2004. PMID: 15520862 Free PMC article.

2

The CDKN2A database: Integrating allelic variants with evolution, structure, function, and disease association.

Murphy JA, Barrantes-Reynolds R, Kocherlakota R, Bond JP, Greenblatt MS. Murphy JA, et al. Hum Mutat. 2004 Oct;24(4):296-304. doi: 10.1002/humu.20083. Hum Mutat. 2004. PMID: 15365986

3

p19ARF directly and differentially controls the functions of c-Myc independently of p53.

Qi Y, Gregory MA, Li Z, Brousal JP, West K, Hann SR. Qi Y, et al. Nature. 2004 Oct 7;431(7009):712-7. doi: 10.1038/nature02958. Epub 2004 Sep 8. Nature. 2004. PMID: 15361884

4

Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.

Aslanian A, Iaquinta PJ, Verona R, Lees JA. Aslanian A, et al. Genes Dev. 2004 Jun 15;18(12):1413-22. doi: 10.1101/gad.1196704. Epub 2004 Jun 2. Genes Dev. 2004. PMID: 15175242 Free PMC article.

5

Familial melanoma, pancreatic cancer and germline CDKN2A mutations.

Goldstein AM. Goldstein AM. Hum Mutat. 2004 Jun;23(6):630. doi: 10.1002/humu.9247. Hum Mutat. 2004. PMID: 15146471

6

A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.

Yakobson E, Eisenberg S, Isacson R, Halle D, Levy-Lahad E, Catane R, Safro M, Sobolev V, Huot T, Peters G, Ruiz A, Malvehy J, Puig S, Chompret A, Avril MF, Shafir R, Peretz H, Bressac-de Paillerets B. Yakobson E, et al. Eur J Hum Genet. 2003 Apr;11(4):288-96. doi: 10.1038/sj.ejhg.5200961. Eur J Hum Genet. 2003. PMID: 12700603

7

Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing.

Sugimoto M, Kuo ML, Roussel MF, Sherr CJ. Sugimoto M, et al. Mol Cell. 2003 Feb;11(2):415-24. doi: 10.1016/s1097-2765(03)00057-1. Mol Cell. 2003. PMID: 12620229 Free article.

8

Hereditary p16-Leiden mutation in a patient with multiple head and neck tumors.

Schneider-Stock R, Giers A, Motsch C, Boltze C, Evert M, Freigang B, Roessner A. Schneider-Stock R, et al. Am J Hum Genet. 2003 Jan;72(1):216-8. doi: 10.1086/345397. Am J Hum Genet. 2003. PMID: 12549483 Free PMC article. No abstract available.

9

ARF mutation accelerates pituitary tumor development in Rb+/- mice.

Tsai KY, MacPherson D, Rubinson DA, Nikitin AY, Bronson R, Mercer KL, Crowley D, Jacks T. Tsai KY, et al. Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16865-70. doi: 10.1073/pnas.262499599. Epub 2002 Dec 16. Proc Natl Acad Sci U S A. 2002. PMID: 12486224 Free PMC article.

10

Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice.

Lund AH, Turner G, Trubetskoy A, Verhoeven E, Wientjens E, Hulsman D, Russell R, DePinho RA, Lenz J, van Lohuizen M. Lund AH, et al. Nat Genet. 2002 Sep;32(1):160-5. doi: 10.1038/ng956. Epub 2002 Aug 19. Nat Genet. 2002. PMID: 12185367

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year